Tumor Targeting of Innate and Adaptive Immunity by the Adoptive Cell Transfer of Engineered T Lymphocytes Co-Expressing iNKT and Tumor-Specific MHC-I TCRs
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-2-s3-p11
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
BMJ